自噬现象在肾纤维化中的作用
The Role of Autophagy in Renal Fibrosis
DOI: 10.12677/ACM.2022.12111515, PDF,    科研立项经费支持
作者: 解雅琪*, 左宏伟*：滨州医学院第二临床医学院，山东 烟台 ；王文亭, 林春华：青岛大学附属烟台毓璜顶医院，山东 烟台 ；王 科#：青岛大学附属医院，山东 青岛
关键词: 自噬；细胞凋亡；肾纤维化；糖尿病肾病；综述；Autophagy； Cell Apoptosis； Renal Fibrosis； Diabetic Nephropathy； Review
摘要: 肾脏纤维化是所有慢性肾病发展为终末期肾病的最终共同途径。自噬是一种高度保守的溶酶体降解途径，在维持所有主要类型的肾细胞，包括肾小管细胞、足细胞、系膜细胞和肾小球内皮细胞的维持中发挥重要作用。自噬功能障碍与各种肾脏病理的发病机制密切相关。本文，我们就自噬在肾脏固有细胞及其在相关肾脏疾病中的病理作用和调控进行综述。探讨针对自噬的途径和针对肾脏纤维化的特异治疗，来预防和治疗肾纤维化和相关肾脏疾病。
Abstract: This renal fibrosis is the final common pathway by which all chronic kidney diseases develop into end-stage renal disease. Autophagy is a highly conserved lysosomal degradation pathway that plays an important role in the maintenance of all major types of renal cells, including tubular cells, podo-cytes, mesangial cells and glomerular endothelial cells. Autophagic dysfunction is closely related to the pathogenesis of various renal pathologies. In this article, we review the role and regulation of autophagy in intrinsic renal cells and related renal diseases. Objective: To explore the specific therapy for renal fibrosis and the approach to autophagy, in order to prevent and treat renal fibro-sis and related renal diseases.
文章引用：解雅琪, 左宏伟, 王文亭, 林春华, 王科. 自噬现象在肾纤维化中的作用[J]. 临床医学进展, 2022, 12(11): 10522-10531. https://doi.org/10.12677/ACM.2022.12111515

参考文献

[1] Klionsky, D.J. (2008) Autophagy Revisited: A Conversation with Christian de Duve. Autophagy, 4, 740-743. [Google Scholar] [CrossRef] [PubMed]
[2] Mizushima, N. and Komatsu, M. (2011) Autophagy: Renovation of Cells and Tissues. Cell, 147, 728-741. [Google Scholar] [CrossRef] [PubMed]
[3] Mizushima, N., Levine, B., Cuervo, A.M. and Klionsky, D.J. (2008) Autophagy Fights Disease through Cellular Self-Digestion. Nature, 451, 1069-1075. [Google Scholar] [CrossRef] [PubMed]
[4] Zaffagnini, G. and Martens, S. (2016) Mechanisms of Selective Autoph-agy. Journal of Molecular Biology, 428, 1714-1724. [Google Scholar] [CrossRef] [PubMed]
[5] Sionov, R.V., Vlahopoulos, S.A. and Granot, Z. (2015) Regulation of Bim in Health and Disease. Oncotarget, 6, 23058-23134. [Google Scholar] [CrossRef] [PubMed]
[6] Dikic, I. and Elazar, Z. (2018) Mechanism and Medical Implications of Mammalian Autophagy. Nature Reviews Molecular Cell Biology, 19, 349-364. [Google Scholar] [CrossRef] [PubMed]
[7] Huber, T.B., Edelstein, C.L., Hartleben, B., Inoki, K., Jiang, M., Koya, D., et al. (2012) Emerging Role of Autophagy in Kidney Function, Diseases and Aging. Au-tophagy, 8, 1009-1031. [Google Scholar] [CrossRef] [PubMed]
[8] Choi, A.M., Ryter, S.W. and Levine, B. (2013) Autophagy in Human Health and Disease. The New England Journal of Medicine, 368, 651-662. [Google Scholar] [CrossRef] 
[9] Ravikumar, B., Sarkar, S., Davies, J.E., Futter, M., Garcia-Arencibia, M., Green-Thompson, Z.W., et al. (2010) Regulation of Mammalian Autophagy in Physiology and Pathophysiology. Physiological Reviews, 90, 1383-1435. [Google Scholar] [CrossRef] [PubMed]
[10] Levine, B. and Kroemer, G. (2008) Autophagy in the Pathogene-sis of Disease. Cell, 132, 27-42. [Google Scholar] [CrossRef] [PubMed]
[11] Yang, Z. and Klionsky, D.J. (2010) Mammalian Autophagy: Core Molecular Machinery and Signaling Regulation. Current Opinion in Cell Biology, 22, 124-131. [Google Scholar] [CrossRef] [PubMed]
[12] Rubinsztein, D.C., Shpilka, T. and Elazar, Z. (2012) Mechanisms of Autophagosome Biogenesis. Current Biology, 22, R29-R34. [Google Scholar] [CrossRef] [PubMed]
[13] Yu, L., Chen, Y. and Tooze, S.A. (2018) Autophagy Pathway: Cellular and Molecular Mechanisms. Autophagy, 14, 207-215. [Google Scholar] [CrossRef] [PubMed]
[14] He, C. and Klionsky, D.J. (2009) Regulation Mechanisms and Signaling Pathways of Autophagy. Annual Review of Genetics, 43, 67-93. [Google Scholar] [CrossRef] [PubMed]
[15] Klionsky, D.J., Abdelmohsen, K., Abe, A., Abedin, M.J., Abeliovich, H., Acevedo, A.A., et al. (2016) Guidelines for the Use and Interpretation of Assays for Monitoring Autophagy (3rd Edition). Autophagy, 12, 1-222. [Google Scholar] [CrossRef] [PubMed]
[16] Mehrpour, M., Esclatine, A., Beau, I. and Codogno, P. (2010) Overview of Macroautophagy Regulation in Mammalian Cells. Cell Research, 20, 748-762. [Google Scholar] [CrossRef] [PubMed]
[17] Pavenstädt, H., Kriz, W. and Kretzler, M. (2003) Cell Biology of the Glo-merular Podocyte. Physiological Reviews, 83, 253-307. [Google Scholar] [CrossRef] [PubMed]
[18] Zhang, L., Livingston, M.J., Chen, J.K. and Dong, Z. (2014) Autophagy in Podocytes. Contributions to Nephrology, 183, 83-100.
[19] Asanuma, K., Tanida, I., Shirato, I., Ueno, T., Takahara, H., Nishitani, T., et al. (2003) MAP-LC3, a Promising Autophagosomal Marker, Is Processed during the Differentiation and Recovery of Podocytes from PAN Ne-phrosis. FASEB Journal, 17, 1165-1167. [Google Scholar] [CrossRef] [PubMed]
[20] Cui, J., Bai, X.Y., Shi, S., Cui, S., Hong, Q., Cai, G., et al. (2012) Age-Related Changes in the Function of Autophagy in Rat Kidneys. Age (Dordrecht, Netherlands), 34, 329-339. [Google Scholar] [CrossRef] [PubMed]
[21] Wanner, N., Hartleben, B., Herbach, N., Goedel, M., Stickel, N., Zeiser, R., et al. (2014) Unraveling the Role of Podocyte Turnover in Glomerular Aging and Injury. Journal of the American Society of Nephrology, 25, 707-716. [Google Scholar] [CrossRef] 
[22] Narita, M., Young, A.R., Arakawa, S., Samarajiwa, S.A., Nakashima, T., Yoshida, S., et al. (2011) Spatial Coupling of mTOR and Autophagy Augments Secretory Phenotypes. Science, 332, 966-970. [Google Scholar] [CrossRef] [PubMed]
[23] Hartleben, B., Wanner, N. and Huber, T.B. (2014) Autophagy in Glomerular Health and Disease. Seminars in Nephrology, 34, 42-52. [Google Scholar] [CrossRef] [PubMed]
[24] Inoki, K. (2014) mTOR Signaling in Autophagy Regulation in the Kidney. Seminars in Nephrology, 34, 2-8.
[25] Yu, L., McPhee, C.K., Zheng, L., Mardones, G.A., Rong, Y., Peng, J., et al. (2010) Termination of Autophagy and Reformation of Lysosomes Regulated by mTOR. Nature, 465, 942-946. [Google Scholar] [CrossRef] [PubMed]
[26] Kim, J., Shon, E., Kim, C.S. and Kim, J.S. (2012) Renal Podo-cyte Injury in a Rat Model of Type 2 Diabetes Is Prevented by Metformin. Experimental Diabetes Research, 2012, Arti-cle ID: 210821.
[27] Xavier, S., Gilbert, V., Rastaldi, M.P., Krick, S., Kollins, D., Reddy, A., et al. (2010) BAMBI Is Expressed in Endothelial Cells and Is Regulated by Lysosomal/Autolysosomal Degradation. PLOS ONE, 5, e12995. [Google Scholar] [CrossRef] [PubMed]
[28] Kimura, T., Takabatake, Y., Takahashi, A., Kaimori, J.Y., Mat-sui, I., Namba, T., et al. (2011) Autophagy Protects the Proximal Tubule from Degeneration and Acute Ischemic Injury. Journal of the American Society of Nephrology, 22, 902-913. [Google Scholar] [CrossRef] 
[29] Liu, S., Hartleben, B., Kretz, O., Wiech, T., Igarashi, P., Mizushima, N., et al. (2012) Autophagy Plays a Critical Role in Kidney Tubule Maintenance, Aging and Ischemia-Reperfusion Injury. Autophagy, 8, 826-837. [Google Scholar] [CrossRef] [PubMed]
[30] Jiang, M., Wei, Q., Dong, G., Komatsu, M., Su, Y. and Dong, Z. (2012) Autophagy in Proximal Tubules Protects against Acute Kidney Injury. Kidney International, 82, 1271-1283. [Google Scholar] [CrossRef] [PubMed]
[31] Havasi, A. and Dong, Z. (2016) Autophagy and Tubular Cell Death in the Kidney. Seminars in Nephrology, 36, 174-188. [Google Scholar] [CrossRef] [PubMed]
[32] Zhang, D., Pan, J., Xiang, X., Liu, Y., Dong, G., Livingston, M.J., et al. (2016) Protein Kinase Cδ Suppresses Autophagy to Induce Kidney Cell Apoptosis in Cisplatin Nephrotoxicity. Journal of the American Society of Nephrology, 28, 1131-1144.
[33] Tang, C., Han, H., Yan, M., Zhu, S., Liu, J., Liu, Z., et al. (2018) PINK1-PRKN/PARK2 Pathway of Mitophagy Is Activated to Protect against Renal Ischemia-Reperfusion Injury. Autophagy, 14, 880-897. [Google Scholar] [CrossRef] [PubMed]
[34] Liu, Y. (2011) Cellular and Molecular Mechanisms of Renal Fibrosis. Nature Reviews Nephrology, 7, 684-696. [Google Scholar] [CrossRef] [PubMed]
[35] Duffield, J.S. (2014) Cellular and Molecular Mechanisms in Kidney Fibrosis. The Journal of Clinical Investigation, 124, 2299-2306. [Google Scholar] [CrossRef] 
[36] Humphreys, B.D. (2018) Mechanisms of Renal Fibrosis. Annual Review of Physiology, 80, 309-326. [Google Scholar] [CrossRef] [PubMed]
[37] Levin, A., Tonelli, M., Bonventre, J., Coresh, J., Donner, J.A., Fogo, A.B., et al. (2017) Global Kidney Health 2017 and beyond: A Roadmap for Closing Gaps in Care, Research, and Policy. The Lancet, 390, 1888-1917.
[38] Brownlee, M. (2005) The Pathobiology of Diabetic Complica-tions: A Unifying Mechanism. Diabetes, 54, 1615-1625. [Google Scholar] [CrossRef] [PubMed]
[39] Forbes, J.M. and Cooper, M.E. (2013) Mechanisms of Diabetic Complications. Physiological Reviews, 93, 137-188. [Google Scholar] [CrossRef] [PubMed]
[40] Abbate, M., Zoja, C. and Remuzzi, G. (2006) How Does Pro-teinuria Cause Progressive Renal Damage. Journal of the American Society of Nephrology, 17, 2974-2984. [Google Scholar] [CrossRef] 
[41] Wellen, K.E. and Thompson, C.B. (2010) Cellular Metabolic Stress: Considering How Cells Respond to Nutrient Excess. Molecular Cell, 40, 323-332.
[42] Zoncu, R., Efeyan, A. and Sa-batini, D.M. (2011) mTOR: From Growth Signal Integration to Cancer, Diabetes and Ageing. Nature Reviews Molecular Cell Biology, 12, 21-35. [Google Scholar] [CrossRef] [PubMed]
[43] Steinberg, G.R. and Kemp, B.E. (2009) AMPK in Health and Disease. Physiological Reviews, 89, 1025-1078. [Google Scholar] [CrossRef] [PubMed]
[44] Lee, J.W., Park, S., Takahashi, Y. and Wang, H.G. (2010) The Association of AMPK with ULK1 Regulates Autophagy. PLOS ONE, 5, e15394. [Google Scholar] [CrossRef] [PubMed]
[45] Kim, J., Kundu, M., Viollet, B. and Guan, K.L. (2011) AMPK and mTOR Regulate Autophagy through Direct Phosphorylation of Ulk1. Nature Cell Biology, 13, 132-141. [Google Scholar] [CrossRef] [PubMed]
[46] Alers, S., Löffler, A.S., Wesselborg, S. and Stork, B. (2012) Role of AMPK-mTOR-Ulk1/2 in the Regulation of Autophagy: Cross Talk, Shortcuts, and Feedbacks. Molecular and Cellular Biology, 32, 2-11. [Google Scholar] [CrossRef] 
[47] Kume, S., Uzu, T., Horiike, K., Chin-Kanasaki, M., Isshiki, K., Araki, S., et al. (2010) Calorie Restriction Enhances Cell Adaptation to Hypoxia through Sirt1-Dependent Mitochondrial Au-tophagy in Mouse Aged Kidney. The Journal of Clinical Investigation, 120, 1043-1055. [Google Scholar] [CrossRef] 
[48] Cantó, C., Gerhart-Hines, Z., Feige, J.N., Lagouge, M., Noriega, L., Milne, J.C., et al. (2009) AMPK Regulates Energy Expenditure by Modulating NAD+ Metabolism and SIRT1 Activity. Nature, 458, 1056-1060. [Google Scholar] [CrossRef] [PubMed]
[49] Ghosh, H.S., McBurney, M. and Robbins, P.D. (2010) SIRT1 Negative-ly Regulates the Mammalian Target of Rapamycin. PLOS ONE, 5, e9199. [Google Scholar] [CrossRef] [PubMed]
[50] Kume, S., Thomas, M.C. and Koya, D. (2012) Nutrient Sensing, Autophagy, and Diabetic Nephropathy. Diabetes, 61, 23-29. [Google Scholar] [CrossRef] [PubMed]
[51] Yang, D., Livingston, M.J., Liu, Z., Dong, G., Zhang, M., Chen, J.K., et al. (2018) Autophagy in Diabetic Kidney Disease: Regula-tion, Pathological Role and Therapeutic Potential. Cellular and Molecular Life Sciences, 75, 669-688. [Google Scholar] [CrossRef] [PubMed]
[52] Mori, H., Inoki, K., Masutani, K., Wakabayashi, Y., Komai, K., Nakagawa, R., et al. (2009) The mTOR Pathway Is Highly Activated in Diabetic Nephropathy and Rapamycin Has a Strong Therapeutic Potential. Biochemical and Biophysical Research Communications, 384, 471-475. [Google Scholar] [CrossRef] [PubMed]
[53] Nagai, K., Matsubara, T., Mima, A., Sumi, E., Kanamori, H., Iehara, N., et al. (2005) Gas6 Induces Akt/mTOR-Mediated Mesangial Hypertrophy in Diabetic Nephropathy. Kidney International, 68, 552-561. [Google Scholar] [CrossRef] [PubMed]
[54] Zhang, M.Z., Wang, Y., Paueksakon, P. and Harris, R.C. (2014) Epidermal Growth Factor Receptor Inhibition Slows Progression of Diabetic Nephropathy in Association with a Decrease in Endoplasmic Reticulum Stress and an Increase in Autophagy. Diabetes, 63, 2063-2072.
[55] Inoki, K., Mori, H., Wang, J., Suzuki, T., Hong, S., Yoshida, S., et al. (2011) mTORC1 Activation in Podocytes Is a Critical Step in the Development of Diabetic Nephropathy in Mice. The Journal of Clinical Investigation, 121, 2181-2196. [Google Scholar] [CrossRef] 
[56] Gödel, M., Hartleben, B., Herbach, N., Liu, S., Zschiedrich, S., Lu, S., et al. (2011) Role of mTOR in Podocyte Function and Diabetic Nephropathy in Humans and Mice. The Journal of Clinical Investigation, 121, 2197-2209. [Google Scholar] [CrossRef] 
[57] Sakaguchi, M., Isono, M., Isshiki, K., Sugimoto, T., Koya, D. and Kashiwagi, A. (2006) Inhibition of mTOR Signaling with Rapamycin Attenuates Renal Hypertrophy in the Early Diabetic Mice. Biochemical and Biophysical Research Communications, 340, 296-301. [Google Scholar] [CrossRef] [PubMed]
[58] Velagapudi, C., Bhandari, B.S., Abboud-Werner, S., Simone, S., Abboud, H.E. and Habib, S.L. (2011) The Tuberin/mTOR Pathway Promotes Apoptosis of Tubular Epithelial Cells in Diabetes. Journal of the American Society of Nephrology, 22, 262-273. [Google Scholar] [CrossRef] 
[59] Wittmann, S., Daniel, C., Stief, A., Vogelbacher, R., Amann, K. and Hugo, C. (2009) Long-Term Treatment of Sirolimus But Not Cyclosporine Ameliorates Diabetic Nephropathy in the Rat. Transplantation, 87, 1290-1299. [Google Scholar] [CrossRef] 
[60] Yang, Y., Wang, J., Qin, L., Shou, Z., Zhao, J., Wang, H., et al. (2007) Rapamycin Prevents Early Steps of the Development of Diabetic Nephropathy in Rats. American Journal of Nephrology, 27, 495-502. [Google Scholar] [CrossRef] [PubMed]
[61] Lloberas, N., Cruzado, J.M., Franquesa, M., Herrero-Fresneda, I., Torras, J., Alperovich, G., et al. (2006) Mammalian Target of Rapamycin Pathway Blockade Slows Progression of Diabetic Kidney Disease in Rats. Journal of the American Society of Nephrology, 17, 1395-1404. [Google Scholar] [CrossRef] 
[62] Sataranatarajan, K., Mariappan, M.M., Lee, M.J., Feliers, D., Choudhury, G.G., Barnes, J.L., et al. (2007) Regulation of Elongation Phase of mRNA Translation in Diabetic Nephrop-athy: Amelioration by Rapamycin. The American Journal of Pathology, 171, 1733-1742. [Google Scholar] [CrossRef] [PubMed]
[63] Stridh, S., Palm, F., Takahashi, T., Ikegami-Kawai, M. and Han-sell, P. (2015) Inhibition of mTOR Activity in Diabetes Mellitus Reduces Proteinuria But Not Renal Accumulation of Hyaluronan. Upsala Journal of Medical Sciences, 120, 233-240. [Google Scholar] [CrossRef] [PubMed]
[64] Fang, L., Zhou, Y., Cao, H., Wen, P., Jiang, L., He, W., et al. (2013) Autophagy Attenuates Diabetic Glomerular Damage through Protection of Hyperglycemia-Induced Podocyte In-jury. PLOS ONE, 8, e60546.
[65] Xiao, T., Guan, X., Nie, L., Wang, S., Sun, L., He, T., et al. (2014) Rapamycin Promotes Podocyte Autophagy and Ameliorates Renal Injury in Diabetic Mice. Molecular and Cellular Biochemistry, 394, 145-154. [Google Scholar] [CrossRef] [PubMed]
[66] Zhao, X., Chen, Y., Tan, X., Zhang, L., Zhang, H., Li, Z., et al. (2018) Advanced Glycation End-Products Suppress Autophagic Flux in Podocytes by Activating Mammalian Target of Rapamycin and Inhibiting Nuclear Translocation of Transcription Factor EB. The Journal of Pathology, 245, 235-248. [Google Scholar] [CrossRef] [PubMed]
[67] Kitada, M., Ogura, Y., Suzuki, T., Sen, S., Lee, S.M., Kanasaki, K., et al. (2016) A Very-Low-Protein Diet Ameliorates Advanced Diabetic Nephropathy through Autophagy Induction by Sup-pression of the mTORC1 Pathway in Wistar Fatty Rats, an Animal Model of Type 2 Diabetes and Obesity. Diabetologia, 59, 1307-1317. [Google Scholar] [CrossRef] [PubMed]
[68] Hasegawa, K., Wakino, S., Simic, P., Sakamaki, Y., Minakuchi, H., Fujimura, K., et al. (2013) Renal Tubular Sirt1 Attenuates Diabetic Albuminuria by Epigenetically Suppressing Clau-din-1 Overexpression in Podocytes. Nature Medicine, 19, 1496-1504. [Google Scholar] [CrossRef] [PubMed]
[69] Ma, L., Fu, R., Duan, Z., Lu, J., Gao, J., Tian, L., et al. (2016) Sirt1 Is Essential for Resveratrol Enhancement of Hypox-ia-Induced Autophagy in the Type 2 Diabetic Nephropathy Rat. Pathology—Research and Practice, 212, 310-318. [Google Scholar] [CrossRef] [PubMed]
[70] Forbes, M.S., Thornhill, B.A. and Chevalier, R.L. (2011) Proximal Tubular Injury and Rapid Formation of Atubular Glomeruli in Mice with Unilateral Ureteral Obstruction: A New Look at an Old Model. The American Journal of Physiology—Renal Physiology, 301, F110-F117. [Google Scholar] [CrossRef] [PubMed]
[71] Li, L., Zepeda-Orozco, D., Black, R. and Lin, F. (2010) Autoph-agy Is a Component of Epithelial Cell Fate in Obstructive Uropathy. The American Journal of Pathology, 176, 1767-1778. [Google Scholar] [CrossRef] [PubMed]
[72] Xu, Y., Ruan, S., Wu, X., Chen, H., Zheng, K. and Fu, B. (2013) Autophagy and Apoptosis in Tubular Cells Following Unilateral Ureteral Obstruction Are Associated with Mitochondrial Oxidative Stress. International Journal of Molecular Medicine, 31, 628-636. [Google Scholar] [CrossRef] [PubMed]
[73] Koesters, R., Kaissling, B., Lehir, M., Picard, N., Theilig, F., Gebhardt, R., et al. (2010) Tubular Overexpression of Transforming Growth Factor-beta1 Induces Autophagy and Fi-brosis But Not Mesenchymal Transition of Renal Epithelial Cells. The American Journal of Pathology, 177, 632-643. [Google Scholar] [CrossRef] [PubMed]
[74] Livingston, M.J., Ding, H.F., Huang, S., Hill, J.A., Yin, X.M. and Dong, Z. (2016) Persistent Activation of Autophagy in Kidney Tubular Cells Promotes Renal Interstitial Fibrosis during Unilateral Ureteral Obstruction. Autophagy, 12, 976-998. [Google Scholar] [CrossRef] [PubMed]
[75] Bellomo, R., Kellum, J.A. and Ronco, C. (2012) Acute Kid-ney Injury. The Lancet, 380, 756-766. [Google Scholar] [CrossRef] 
[76] Zuk, A. and Bonventre, J.V. (2016) Acute Kidney Injury. Annual Review of Medicine, 67, 293-307. [Google Scholar] [CrossRef] [PubMed]
[77] Linkermann, A., Chen, G., Dong, G., Kunzendorf, U., Krautwald, S. and Dong, Z. (2014) Regulated Cell Death in AKI. Journal of the American Society of Nephrology, 25, 2689-2701. [Google Scholar] [CrossRef] 
[78] Periyasamy-Thandavan, S., Jiang, M., Wei, Q., Smith, R., Yin, X.M. and Dong, Z. (2008) Autophagy Is Cytoprotective during Cisplatin Injury of Renal Proximal Tubular Cells. Kidney International, 74, 631-640. [Google Scholar] [CrossRef] [PubMed]
[79] Yang, C., Kaushal, V., Shah, S.V. and Kaushal, G.P. (2008) Autophagy Is Associated with Apoptosis in Cisplatin Injury to Renal Tubular Epithelial Cells. The American Journal of Physiolo-gy—Renal Physiology, 294, F777-F787. [Google Scholar] [CrossRef] [PubMed]
[80] Jiang, M., Liu, K., Luo, J. and Dong, Z. (2010) Autophagy Is a Renoprotective Mechanism during in Vitro Hypoxia and in Vivo Ischemia-Reperfusion Injury. The American Journal of Pathology, 176, 1181-1192. [Google Scholar] [CrossRef] [PubMed]
[81] Cheng, H., Fan, X., Lawson, W.E., Paueksakon, P. and Harris, R.C. (2015) Telomerase Deficiency Delays Renal Recovery in Mice after Ischemia-Reperfusion Injury by Impairing Au-tophagy. Kidney International, 88, 85-94. [Google Scholar] [CrossRef] [PubMed]
[82] Takahashi, A., Kimura, T., Takabatake, Y., Namba, T., Kaimori, J., Kitamura, H., et al. (2012) Autophagy Guards against Cisplatin-Induced Acute Kidney Injury. The American Journal of Pathology, 180, 517-525. [Google Scholar] [CrossRef] [PubMed]

为你推荐